BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Powell BD, Saxon LA, Boehmer JP, Day JD, Gilliam FR 3rd, Heidenreich PA, Jones PW, Rousseau MJ, Hayes DL. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol. 2013;62:1674-1679. [PMID: 23810882 DOI: 10.1016/j.jacc.2013.04.083] [Cited by in Crossref: 100] [Cited by in F6Publishing: 60] [Article Influence: 12.5] [Reference Citation Analysis]
Number Citing Articles
1 Ebrille E, Konecny T, Konecny D, Spacek R, Jones P, Ambroz P, DeSimone CV, Powell BD, Hayes DL, Friedman PA, Asirvatham SJ. Correlation of geomagnetic activity with implantable cardioverter defibrillator shocks and antitachycardia pacing. Mayo Clin Proc 2015;90:202-8. [PMID: 25659238 DOI: 10.1016/j.mayocp.2014.11.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ruwald AC, Schuger C, Moss AJ, Kutyifa V, Olshansky B, Greenberg H, Cannom DS, Estes NA, Ruwald MH, Huang DT, Klein H, McNitt S, Beck CA, Goldstein R, Brown MW, Kautzner J, Shoda M, Wilber D, Zareba W, Daubert JP. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Circ Arrhythm Electrophysiol 2014;7:785-92. [PMID: 25136077 DOI: 10.1161/CIRCEP.114.001623] [Cited by in Crossref: 88] [Cited by in F6Publishing: 13] [Article Influence: 12.6] [Reference Citation Analysis]
3 Li A, Kaura A, Sunderland N, Dhillon PS, Scott PA. The Significance of Shocks in Implantable Cardioverter Defibrillator Recipients. Arrhythm Electrophysiol Rev 2016;5:110-6. [PMID: 27617089 DOI: 10.15420/AER.2016.12.2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
4 Guédon-Moreau L, Kouakam C, Klug D, Marquié C, Brigadeau F, Boulé S, Blangy H, Lacroix D, Clémenty J, Sadoul N, Kacet S. Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a substudy of the ECOST trial. J Cardiovasc Electrophysiol 2014;25:763-70. [PMID: 24602062 DOI: 10.1111/jce.12405] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
5 Merchant FM, Jones P, Wehrenberg S, Lloyd MS, Saxon LA. Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life. J Am Heart Assoc 2014;3:e001289. [PMID: 25385346 DOI: 10.1161/JAHA.114.001289] [Cited by in Crossref: 30] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
6 Shinbane JS, Saxon LA. Digital monitoring and care: Virtual medicine. Trends Cardiovasc Med 2016;26:722-30. [PMID: 27373351 DOI: 10.1016/j.tcm.2016.05.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Strickberger SA, Canby R, Cooper J, Coppess M, Doshi R, John R, Connolly AT, Roberts G, Karst E, Daoud EG. Association of Antitachycardia Pacing or Shocks With Survival in 69,000 Patients With an Implantable Defibrillator: ATP and Mortality in 69,000 ICD Patients. J Cardiovasc Electrophysiol 2017;28:416-22. [DOI: 10.1111/jce.13170] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 6.8] [Reference Citation Analysis]
8 Callum K, Graune C, Bowman E, Molden E, Leslie SJ. Remote monitoring of implantable defibrillators is associated with fewer inappropriate shocks and reduced time to medical assessment in a remote and rural area. World J Cardiol 2021;13:46-54. [PMID: 33791078 DOI: 10.4330/wjc.v13.i3.46] [Reference Citation Analysis]
9 Söth-hansen M, Witt CT, Rasmussen M, Kristensen J, Gerdes C, Nielsen JC. Time until diagnosis of clinical events with different remote monitoring systems in implantable cardioverter-defibrillator patients. Heart Rhythm 2018;15:1648-54. [DOI: 10.1016/j.hrthm.2018.05.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
10 Wei C, Qian P, Tedrow U, Mak R, Zei PC. Non-invasive Stereotactic Radioablation: A New Option for the Treatment of Ventricular Arrhythmias. Arrhythm Electrophysiol Rev 2020;8:285-93. [PMID: 32685159 DOI: 10.15420/aer.2019.04] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
11 Bristow MR, Saxon LA, Feldman AM, Mei C, Anderson SA, DeMets DL. Lessons Learned and Insights Gained in the Design, Analysis, and Outcomes of the COMPANION Trial. JACC Heart Fail 2016;4:521-35. [PMID: 27289408 DOI: 10.1016/j.jchf.2016.02.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
12 Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, Lim HS, Lip GYH, Nava-Townsend S, Pak HN, Diez GR, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Pava Molano LF, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C; ESC Scientific Document Group. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. Heart Rhythm 2020;17:e269-316. [PMID: 32553607 DOI: 10.1016/j.hrthm.2020.05.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Alvi RM, Neilan AM, Tariq N, Awadalla M, Rokicki A, Hassan M, Afshar M, Mulligan CP, Triant VA, Zanni MV, Neilan TG. Incidence, Predictors, and Outcomes of Implantable Cardioverter-Defibrillator Discharge Among People Living With HIV. J Am Heart Assoc 2018;7:e009857. [PMID: 30371221 DOI: 10.1161/JAHA.118.009857] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Al-khatib SM, Daubert JP, Anstrom KJ, Daoud EG, Gonzalez M, Saba S, Jackson KP, Reece T, Gu J, Pokorney SD, Granger CB, Hess PL, Mark DB, Stevenson WG. Catheter Ablation for Ventricular Tachycardia in Patients with an Implantable Cardioverter Defibrillator (CALYPSO) Pilot Trial: Catheter Ablation for Ventricular Tachycardia. J Cardiovasc Electrophysiol 2015;26:151-7. [DOI: 10.1111/jce.12567] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 5.9] [Reference Citation Analysis]
15 Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, Mcguire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S; Document Reviewers. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace 2016;18:159-83. [PMID: 26585598 DOI: 10.1093/europace/euv411] [Cited by in Crossref: 73] [Cited by in F6Publishing: 35] [Article Influence: 12.2] [Reference Citation Analysis]
16 Stevenson WG. Current treatment of ventricular arrhythmias: state of the art. Heart Rhythm 2013;10:1919-26. [PMID: 24120875 DOI: 10.1016/j.hrthm.2013.10.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
17 Kulkarni N, Link MS. Causes and Prevention of Inappropriate Implantable Cardioverter-Defibrillator Shocks. Card Electrophysiol Clin 2018;10:67-74. [PMID: 29428143 DOI: 10.1016/j.ccep.2017.11.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Wising J, Mattsson G, Rambaree K, Willmer M, Wallhagen M, Magnusson P. 'Life with a device': the octogenarians' experiences with an implantable cardioverter-defibrillator-a qualitative study. Eur J Cardiovasc Nurs 2021:zvab033. [PMID: 33928354 DOI: 10.1093/eurjcn/zvab033] [Reference Citation Analysis]
19 Brisben AJ, Burke MC, Knight BP, Hahn SJ, Herrmann KL, Allavatam V, Mahajan D, Sanghera R, Gold MR. A New Algorithm to Reduce Inappropriate Therapy in the S-ICD System: A New Algorithm to Reduce Inappropriate Therapy. J Cardiovasc Electrophysiol 2015;26:417-23. [DOI: 10.1111/jce.12612] [Cited by in Crossref: 86] [Cited by in F6Publishing: 42] [Article Influence: 14.3] [Reference Citation Analysis]
20 Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Heart Rhythm. 2016;13:e50-e86. [PMID: 26607062 DOI: 10.1016/j.hrthm.2015.11.018] [Cited by in Crossref: 136] [Cited by in F6Publishing: 68] [Article Influence: 22.7] [Reference Citation Analysis]
21 Bunch TJ, Anderson JL. Adjuvant Antiarrhythmic Therapy in Patients with Implantable Cardioverter Defibrillators. Am J Cardiovasc Drugs 2014;14:89-100. [DOI: 10.1007/s40256-013-0056-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
22 Al-Khatib SM, Friedman P, Ellenbogen KA. Defibrillators: Selecting the Right Device for the Right Patient. Circulation 2016;134:1390-404. [PMID: 27799257 DOI: 10.1161/CIRCULATIONAHA.116.021889] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 4.3] [Reference Citation Analysis]
23 Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, S Lim H, Lip GYH, Nava-Townsend S, Pak HN, Rodríguez Diez G, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Molano LFP, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. J Arrhythm 2020;36:553-607. [PMID: 32782627 DOI: 10.1002/joa3.12338] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
24 Looi K, Tang A, Agarwal S. Ventricular arrhythmia storm in the era of implantable cardioverter-defibrillator. Postgrad Med J 2015;91:519-26. [DOI: 10.1136/postgradmedj-2015-133550] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Fowler LH. Nursing Management for Patients Postoperative Cardiac Implantable Electronic Device Placement. Crit Care Nurs Clin North Am 2019;31:65-76. [PMID: 30736936 DOI: 10.1016/j.cnc.2018.11.007] [Reference Citation Analysis]
26 Scott PA, Silberbauer J, Mcdonagh TA, Murgatroyd FD. Impact of prolonged implantable cardioverter-defibrillator arrhythmia detection times on outcomes: A meta-analysis. Heart Rhythm 2014;11:828-35. [DOI: 10.1016/j.hrthm.2014.02.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
27 Zdarek J, Israel CW. Detection and discrimination of tachycardia in ICDs manufactured by St. Jude Medical. Herzschr Elektrophys 2016;27:226-39. [DOI: 10.1007/s00399-016-0455-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
28 Santangeli P, Rame JE, Birati EY, Marchlinski FE. Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure. Journal of the American College of Cardiology 2017;69:1842-60. [DOI: 10.1016/j.jacc.2017.01.047] [Cited by in Crossref: 52] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
29 Saxon LA. The Subcutaneous Implantable Defibrillator: A New Technology That Raises an Existential Question for the Implantable Cardioverter-Defibrillator. Circulation 2013;128:938-40. [DOI: 10.1161/circulationaha.113.004794] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
30 Rajamani K, Goldberg AS, Wilkoff BL. Shock Avoidance and the Newer Tachycardia Therapy Algorithms. Cardiology Clinics 2014;32:191-200. [DOI: 10.1016/j.ccl.2014.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
31 Providência R, Boveda S, Lambiase P, Defaye P, Algalarrondo V, Sadoul N, Piot O, Klug D, Perier M, Bouzeman A, Gras D, Fauchier L, Bordachar P, Babuty D, Deharo J, Leclercq C, Marijon E. Prediction of Nonarrhythmic Mortality in Primary Prevention Implantable Cardioverter-Defibrillator Patients With Ischemic and Nonischemic Cardiomyopathy. JACC: Clinical Electrophysiology 2015;1:29-37. [DOI: 10.1016/j.jacep.2015.01.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
32 Erath JW, Vamos M, Hohnloser SH. Effects of digitalis on mortality in a large cohort of implantable cardioverter defibrillator recipients: results of a long-term follow-up study in 1020 patients. Eur Heart J Cardiovasc Pharmacother 2016;2:168-74. [DOI: 10.1093/ehjcvp/pvw008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
33 DeMaria AN, Adler ED, Bax JJ, Ben-Yehuda O, Feld GK, Greenberg BH, Hall JL, Hlatky MA, Lew WY, Lima JA, Mahmud E, Maisel AS, Narayan SM, Nissen SE, Sahn DJ, Tsimikas S. Highlights of the year in JACC 2013. J Am Coll Cardiol 2014;63:570-602. [PMID: 24524815 DOI: 10.1016/j.jacc.2014.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Mahajan D, Dong Y, Saxon LA, Cha Y, Gilliam FR, Asirvatham SJ, Cesario DA, Jones PW, Seth M, Powell BD. Performance of an Automatic Arrhythmia Classification Algorithm: Comparison to the ALTITUDE Electrophysiologist Panel Adjudications: AUTOMATIC EPISODE CLASSIFICATION ALGORITHM PERFORMANCE. Pacing and Clinical Electrophysiology 2014;37:889-99. [DOI: 10.1111/pace.12367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
35 Shah BK. Optimal Implantable Cardioverter Defibrillator Programming. Cardiol Rev 2017;25:30-5. [PMID: 27922468 DOI: 10.1097/CRD.0000000000000133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
36 Kowlgi GN, Cha Y. Management of ventricular electrical storm: a contemporary appraisal. EP Europace 2020;22:1768-80. [DOI: 10.1093/europace/euaa232] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
37 Poole JE, Gold MR. Who Should Receive the Subcutaneous Implanted Defibrillator?: The Subcutaneous Implantable Cardioverter Defibrillator (ICD) Should Be Considered in all ICD Patients Who Do Not Require Pacing. Circ: Arrhythmia and Electrophysiology 2013;6:1236-45. [DOI: 10.1161/circep.113.000481] [Cited by in Crossref: 31] [Cited by in F6Publishing: 4] [Article Influence: 3.9] [Reference Citation Analysis]
38 Bhavnani SP, Giedrimiene D, Coleman CI, Guertin D, Azeem M, Kluger J. The healthcare utilization and cost of treating patients experiencing inappropriate implantable cardioverter defibrillator shocks: a propensity score study. Pacing Clin Electrophysiol 2014;37:1315-23. [PMID: 25139346 DOI: 10.1111/pace.12465] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
39 Darma A, Bertagnolli L, Dinov B, Torri F, Dagres N, Bollmann A, Hindricks G, Arya A. VT ablation in geriatric patients with structural heart disease: Should there still be an age limit? J Cardiovasc Electrophysiol 2021;32:766-71. [PMID: 33428325 DOI: 10.1111/jce.14873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Escande W, Marijon E, Defaye P, Piot O, Leclercq C, Sadoul N, Deharo J, Empana J, Boveda S, Klug D. Electrical Storms in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention. Journal of the American College of Cardiology 2016;68:1248-50. [DOI: 10.1016/j.jacc.2016.06.039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
41 Aksu T, Guler TE, Golcuk E, Ozcan KS, Erden I. Successful focal ablation in a patient with electrical storm in the early postinfarction period: case report. Int Med Case Rep J 2015;8:59-63. [PMID: 25767407 DOI: 10.2147/IMCRJ.S79378] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
42 Segreti L, Di Cori A, Zucchelli G, Soldati E, Coluccia G, Viani S, Paperini L, Bongiorni MG. A Questionable Indication For ICD Extraction After Successful VT Ablation. J Atr Fibrillation 2015;7:1172. [PMID: 27957158 DOI: 10.4022/jafib.1172] [Reference Citation Analysis]
43 Meyer TE, Kiernan MS, Mcmanus DD, Shih J. Decision-Making Under Uncertainty in Advanced Heart Failure. Curr Heart Fail Rep 2014;11:188-96. [DOI: 10.1007/s11897-014-0195-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
44 Mcleod CJ, Boersma L, Okamura H, Friedman PA. The subcutaneous implantable cardioverter defibrillator: state-of-the-art review. European Heart Journal 2017;38:247-57. [DOI: 10.1093/eurheartj/ehv507] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
45 Aktaş MK, Younis A, Zareba W, Kutyifa V, Klein H, Daubert JP, Estes M, McNitt S, Polonsky B, Goldenberg I. Survival After Implantable Cardioverter-Defibrillator Shocks. J Am Coll Cardiol 2021;77:2453-62. [PMID: 34016257 DOI: 10.1016/j.jacc.2021.03.329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Qian Z, Zhang Z, Guo J, Wang Y, Hou X, Feng G, Zou J. Association of Implantable Cardioverter Defibrillator Therapy with All-Cause Mortality-A Systematic Review and Meta-Analysis. Pacing Clin Electrophysiol 2016;39:81-8. [PMID: 26470761 DOI: 10.1111/pace.12766] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
47 Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. J Arrhythm 2016;32:1-28. [PMID: 26949427 DOI: 10.1016/j.joa.2015.12.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
48 Mustafa U, Dherange P, Reddy R, DeVillier J, Chong J, Ihsan A, Jones R, Duddyala N, Reddy P, Dominic P. Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2018;7:e010156. [PMID: 30554547 DOI: 10.1161/JAHA.118.010156] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
49 Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, Lim HS, Lip GYH, Nava-Townsend S, Pak HN, Rodríguez Diez G, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Pava Molano LF, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C; ESC Scientific Document Group. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. Europace 2020;22:1147-8. [PMID: 32538434 DOI: 10.1093/europace/euaa065] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 22.0] [Reference Citation Analysis]
50 Cantillon DJ, Wilkoff BL. Antitachycardia pacing for reduction of implantable cardioverter-defibrillator shocks. Heart Rhythm. 2015;12:1370-1375. [PMID: 25708880 DOI: 10.1016/j.hrthm.2015.02.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
51 Kramer DB, Mitchell SL, Monteiro J, Jones PW, Normand SL, Hayes DL, Reynolds MR. Patient Activity and Survival Following Implantable Cardioverter-Defibrillator Implantation: The ALTITUDE Activity Study. J Am Heart Assoc 2015;4:e001775. [PMID: 25979902 DOI: 10.1161/JAHA.115.001775] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
52 Yousuf O, Spragg DD. ICD Therapy-Can We Make a Life-Saving Device Less Lethal?: Editorial Comment. J Cardiovasc Electrophysiol 2016;27:200-2. [DOI: 10.1111/jce.12883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
53 Pianca N, Zaglia T, Mongillo M. Will cardiac optogenetics find the way through the obscure angles of heart physiology? Biochem Biophys Res Commun 2017;482:515-23. [PMID: 27871856 DOI: 10.1016/j.bbrc.2016.11.104] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
54 Rozner MA, Kahl EA, Schulman PM. Inappropriate Implantable Cardioverter-Defibrillator Therapy During Surgery: An Important and Preventable Complication. Journal of Cardiothoracic and Vascular Anesthesia 2017;31:1037-41. [DOI: 10.1053/j.jvca.2016.11.036] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
55 Miller JC, Skoll D, Saxon LA. Home Monitoring of Cardiac Devices in the Era of COVID-19. Curr Cardiol Rep 2020;23:1. [PMID: 33216256 DOI: 10.1007/s11886-020-01431-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
56 Sun YX, Gao J, Jiang CY, Xue YM, Xu YZ, Liu G, Guo JH, Sheng X, Ye Y, He H, Zhao YT, Barajas-Martinez H, Fu GS, Hu D. T Wave Safety Margin during the Process of ICD Implantation As a Novel Predictor of T Wave Oversensing. Front Physiol 2017;8:659. [PMID: 28919866 DOI: 10.3389/fphys.2017.00659] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Sanders P, Connolly AT, Nabutovsky Y, Fischer A, Saeed M. Increased Hospitalizations and Overall Healthcare Utilization in Patients Receiving Implantable Cardioverter-Defibrillator Shocks Compared With Antitachycardia Pacing. JACC: Clinical Electrophysiology 2018;4:243-53. [DOI: 10.1016/j.jacep.2017.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
58 Kleemann T, Strauss M, Kouraki K, Werner N, Zahn R. Prognostic relevance of new onset arrhythmia and ICD shocks in primary prophylactic ICD patients. Clin Res Cardiol 2020;109:89-95. [DOI: 10.1007/s00392-019-01491-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
59 Proietti R, Labos C, Davis M, Thanassoulis G, Santangeli P, Russo V, Di Biase L, Roux JF, Verma A, Natale A, Essebag V. A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality. Can J Cardiol 2015;31:270-7. [PMID: 25746019 DOI: 10.1016/j.cjca.2014.11.023] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 5.6] [Reference Citation Analysis]
60 Barold SS, Herweg B. Cardiac Resynchronization in Patients with Atrial Fibrillation. J Atr Fibrillation 2015;8:1383. [PMID: 27957235 DOI: 10.4022/jafib.1383] [Cited by in F6Publishing: 1] [Reference Citation Analysis]